|
Profits of the pandemic: Moderna gives Boston's property market a shot in the arm after executives splashed out millions on luxury homes near pharma giant's HQ after COVID vaccine sent profits soaring
[Daily Mail, where America gets its news] - Moderna's executives and staff are hoovering up premium real estate close to the company's headquarters in Boston and beyond
- This comes on the back of the company's rapid growth during the Covid-19 pandemic which saw Moderna's employee count go from a few hundred to over 3,000 in two years
- One scientist spent over $11 million on property less than 12 months after joining the company
- Shares of the company are up from $28 in early 2020 to $166 at the time of writing. The stock peaked at nearly $500 in August 2021
Posted by: Skidmark 2022-07-24 |
